DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine

144 0
DC Medicaid will cover the first and only FDA-cleared, non-drug, non-disruptive treatment for both acute attacks and prevention of migraines with or without aura in adolescents.
DC Medicaid is the second insurance plan in the country to cover the REN.
In addition to the VA, DC Medicaid is the second federal insurance plan to cover the Nerivio REN Wearable, which can help people living with migraines.
In addition to the VA, DC Medicaid is the second federal insurance plan to cover the Nerivio REN Wearable, which can help people living with migraines.
DC's Medicaid decision is significant in setting the course for additional federally funded programs as well as commercial insurance providers across the U.S.
The Director of the Headache and Facial Pain Center said he was pleased that DC Medicaid would cover the REN Wearable for both preventative and acute treatment of migraines.
The Director of the Headache Program at Children's National Hospital in Washington D.C. said the news was great.
In the U.S., 40 million people suffer from migraines, and having insurance coverage is important for most of them.
Alon Ironi, CEO of Theranica, said that a recent report states that eight in 10 patients say limited access to care leads to more frequent and severe migraines.
To download a prescription form, please visit Nerivio.com.
There are nociceptive nerve fibers in the arm which can be activated by the REN.
Theranica is dedicated to creating effective, safe, affordable, low-side-effect therapies for pain conditions.
Theranica Contact
Ronen Jashek is protected by an email.
Grey Matter Marketing has a media contact.
Theranica is the source.
Theranica is a company specializing in digital therapies for pain.
Theranica has achieved remarkable achievements and robust growth throughout the year.

Source prnewswire

No Comments

Leave a Comment

Your email address will not be published. Required fields are marked *